Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MS.

IF 3.2 Q1 SPORT SCIENCES
BMJ Open Sport & Exercise Medicine Pub Date : 2026-02-19 eCollection Date: 2026-01-01 DOI:10.1136/bmjsem-2025-003181
Lisa Grech, Belinda Beck, David Scott, Marc Sim, Jakub Mesinovic, Paul Jansons, Fernanda Rodrigues Fonseca, Julie Abimanyi-Ochom, Michelle Allan, Stefan Blum, Ernest Butler, William Carroll, Nigel Caswell, Peter Ebeling, Vanessa Gan, Alan Herschtal, Nevin John, Allan Kermode, Linh Le-Kavanagh, Shalika Bohingamu Mudiyanselage, Lynne Elizabeth Ohman, Mia Poposka, Alison Reece, Phoebe Sansom, Charlotte Scroggie, Christopher Todaro, Jennifer Watts, Ayse Zengin
{"title":"Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MS.","authors":"Lisa Grech, Belinda Beck, David Scott, Marc Sim, Jakub Mesinovic, Paul Jansons, Fernanda Rodrigues Fonseca, Julie Abimanyi-Ochom, Michelle Allan, Stefan Blum, Ernest Butler, William Carroll, Nigel Caswell, Peter Ebeling, Vanessa Gan, Alan Herschtal, Nevin John, Allan Kermode, Linh Le-Kavanagh, Shalika Bohingamu Mudiyanselage, Lynne Elizabeth Ohman, Mia Poposka, Alison Reece, Phoebe Sansom, Charlotte Scroggie, Christopher Todaro, Jennifer Watts, Ayse Zengin","doi":"10.1136/bmjsem-2025-003181","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>People with multiple sclerosis (MS) engage in less physical activity and experience higher rates of osteoporosis, falls and fractures than the general population, contributing to reduced health-related quality of life (HRQoL) and increased healthcare costs. High-intensity resistance and impact training (HiRIT) has beneficial effects on bone, muscle and physical function in other populations, but its effectiveness in people with MS is unclear.</p><p><strong>Methods and analysis: </strong>STRONG-MS is a codesigned, clinician-led, single-blind, randomised controlled trial evaluating the effect of a HiRIT programme, ONERO, on HRQoL for people with MS. Secondary aims include assessing changes in bone mineral density, body composition, physical function, fatigue, mood as well as intervention safety, feasibility, acceptability, sustainability and cost-effectiveness. One hundred and eighty participants will be randomised (2:1) to ONERO or usual care for 12 months. The intervention comprises two times weekly, supervised, small-group sessions delivered by accredited allied health professionals. Outcomes will be assessed at 12 and 24 months using intention-to-treat analyses. Sustainability will be evaluated during a second 12-month period, during which participants fund ongoing participation privately or through support schemes.</p><p><strong>Ethics and dissemination: </strong>The study has approval from a Health Human Research Ethics Committee. All participants will provide written informed consent. Findings will be disseminated through peer-reviewed publications, conference presentations and summaries for participants, consumer representatives and community organisations. This study will provide novel evidence on the ability of the ONERO to improve HRQoL and musculoskeletal health in people with MS as well as its feasibility, acceptability and sustainability, to inform poststudy implementation.</p>","PeriodicalId":47417,"journal":{"name":"BMJ Open Sport & Exercise Medicine","volume":"12 1","pages":"e003181"},"PeriodicalIF":3.2000,"publicationDate":"2026-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12927361/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Sport & Exercise Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjsem-2025-003181","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"SPORT SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: People with multiple sclerosis (MS) engage in less physical activity and experience higher rates of osteoporosis, falls and fractures than the general population, contributing to reduced health-related quality of life (HRQoL) and increased healthcare costs. High-intensity resistance and impact training (HiRIT) has beneficial effects on bone, muscle and physical function in other populations, but its effectiveness in people with MS is unclear.

Methods and analysis: STRONG-MS is a codesigned, clinician-led, single-blind, randomised controlled trial evaluating the effect of a HiRIT programme, ONERO, on HRQoL for people with MS. Secondary aims include assessing changes in bone mineral density, body composition, physical function, fatigue, mood as well as intervention safety, feasibility, acceptability, sustainability and cost-effectiveness. One hundred and eighty participants will be randomised (2:1) to ONERO or usual care for 12 months. The intervention comprises two times weekly, supervised, small-group sessions delivered by accredited allied health professionals. Outcomes will be assessed at 12 and 24 months using intention-to-treat analyses. Sustainability will be evaluated during a second 12-month period, during which participants fund ongoing participation privately or through support schemes.

Ethics and dissemination: The study has approval from a Health Human Research Ethics Committee. All participants will provide written informed consent. Findings will be disseminated through peer-reviewed publications, conference presentations and summaries for participants, consumer representatives and community organisations. This study will provide novel evidence on the ability of the ONERO to improve HRQoL and musculoskeletal health in people with MS as well as its feasibility, acceptability and sustainability, to inform poststudy implementation.

临床主导的单盲随机对照试验,评估高强度抵抗和冲击训练干预对改善多发性硬化症患者健康相关生活质量的疗效:STRONG-MS方案
与一般人群相比,多发性硬化症(MS)患者体力活动较少,骨质疏松症、跌倒和骨折发生率较高,导致健康相关生活质量(HRQoL)降低,医疗费用增加。高强度抵抗和冲击训练(HiRIT)对其他人群的骨骼、肌肉和身体功能有有益的影响,但其对多发性硬化症患者的有效性尚不清楚。方法和分析:STRONG-MS是一项共同设计、临床主导、单盲、随机对照试验,评估HiRIT项目ONERO对ms患者HRQoL的影响。次要目的包括评估骨矿物质密度、身体成分、身体功能、疲劳、情绪的变化,以及干预的安全性、可行性、可接受性、可持续性和成本效益。180名参与者将随机分配(2:1)至ONERO或常规治疗组,为期12个月。干预措施包括每周两次由经认可的专职保健专业人员提供的有监督的小组会议。将在12个月和24个月时使用意向治疗分析评估结果。可持续性将在第二个12个月期间进行评估,在此期间,参与者将通过私人或支持计划为持续参与提供资金。伦理和传播:该研究已获得健康人类研究伦理委员会的批准。所有参与者将提供书面知情同意书。调查结果将通过同行评审的出版物、会议报告和摘要传播给与会者、消费者代表和社区组织。本研究将为ONERO改善MS患者HRQoL和肌肉骨骼健康的能力以及其可行性、可接受性和可持续性提供新的证据,为研究后的实施提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.10
自引率
4.20%
发文量
106
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书